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Abstract
Ovarian cancer is the deadliest of all gynecologic cancers; yet public discourse about and
understanding of the disease is limited. Metaphors used to discuss the ovaries and ovarian
cancer may have a role to play in the limited public discourse about the disease. In this
article, I offer a critical analysis of the limited visibility for ovarian cancer in the public
sphere using Angelina Jolie’s case as an example. Jolie announced in 2013 that she had
had double mastectomy and may in the future remove her ovaries because of an inherited
faulty BRCA1 gene and a family history of cancer. I argue that presentation of Jolie’s
decision as coming from an informed woman who understood her medical choices,
coupled with public perception of the breast as a symbol of sexuality, made the public to
be more receptive of the decision. I contend further, however, that making her plan for
preventative treatment of ovarian cancer secondary to that of breast cancer even though
her risk of dying from ovarian cancer is higher, points to current public notions of ovarian
cancer. The breasts are sexualized in American culture hence the “heavy” media presence
of Jolie’s mastectomy but an absence of public discourse about ovarian cancer.
By using Angelina Jolie’s situation as a case in point, I do not mean to suggest that her
decision was right or wrong; neither am I advocating for removal of healthy ovaries. I am
only using her case to highlight how current discussion (or non-discussion) of ovarian
cancer does little to bring the severity of the disease to the public radar.
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Angelina Jolie’s ovaries: Influence of metaphors of the ovary and ovarian cancer on
public discourse of ovarian cancer
Introduction
Ovarian cancer is the deadliest of all gynecologic cancers. It has the lowest
survival rate and more than half of women diagnosed with the disease will die within five
years (National Cancer Institute, National Institutes of Health & U.S. Department of
Health and Human Services, 2012). About 1.3 percent of women will be diagnosed with
ovarian cancer in their lifetime (National Cancer Institute, 2012; National Cancer
Institute, National Institutes of Health, and U.S. Department of Health and Human
Services, 2012). The majority of women with ovarian cancer are diagnosed at an
advanced stage of the disease, contributing to the high recurrence and mortality rates of
the disease (Schink, J. C., 1999). Added to this is the gloomy fact that medical testing for
the disease is often inaccurate (Reinberg, 2005). Thus, the disease has long been
described the “silent killer” because it supposedly presents no obvious symptoms until it
has advanced. However, most patients and survivors of the disease claim it actually
presents “shouting” symptoms even at its early stages just that these signs are too general
and most women do not take them seriously (Gubar, 2012; Holmes, 2006). Holmes
(2006) recounts retrospectively that prior to her diagnosis with ovarian cancer “I did
know of the changes I now call cancer, but I didn’t know what I knew” (p. 476). Even
though ovarian cancer kills more women than breast cancer, breast cancer gets more
attention in terms of research and funding and thus more awareness and public education
than other cancers that affect women (Kitzinger, 2000).
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The risk of ovarian cancer is higher for some women than for others. Women with
family history of ovarian and/or breast cancer and those with some gene mutations are
considered at risk. Mutations in the BRCA1 and BRCA2 genes are known to be
responsible for some percentage of epithelial ovarian cancer and breast cancer (Easton et
al., 1995; King, Marks & Mandell, 2003). When identified, women in this category
undergo genetic testing and are referred to genetic counselling where oophorectomy
(surgical removal of ovaries) is recommended if childbearing is not desired; however, if
the woman is considering having children, it is recommended she undergoes periodic
screening for early detection of the disease (Holmes, 2006). This is based on the notion
that “hereditary determines risk” (Ji, 2014, para. 16). Oophorectomy as preventative
treatment option for ovarian cancer is known to reduce risk of disease but does not
eliminate it entirely, and whether it impacts survival depends on early diagnosis of the
disease (Kauff et al., 2002). On the other hand, it leads to conditions such as medicallyinduced menopause and attendant problems including cardiovascular disease, postsurgery infections, among others (Finch et al., 2011).
Some women see oophorectomy as a way of taking control of their health and the
disease so as to avoid putting themselves and loved ones through the suffering brought on
by the disease. Hallowell (2006) found that at-risk women’s choice of treatment option
for ovarian cancer is influenced by reflections on experiences of relatives affected by the
disease and perceptions of what the future holds for them (at-risk women) and their
families. Thus, a decision for treatment of ovarian cancer in the present is influenced by
both past and future considerations of pain and suffering for self and others (Hallowell,
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2006). However, some scholars argue that this radical treatment option is unwarranted
and may be influenced by misinformation about the disease (Ji, 2014).
In this article, I use the case of U.S. actress and director Angelina Jolie to argue
that metaphors of the ovaries and ovarian cancer influence social constructions and public
discourse of ovarian cancer. I decided to focus on Angelina Jolie because she is a public
figure, her case is recent, and her announcement about having mastectomy generated a lot
of public discussion about cancer (Michel, 2014). Jolie is an Oscar-winning actress and
director, ambassador for the United Nations High Commissioner for Refugees (UNHCR),
author, and mother (Biography, 2014; Michel, 2014). She is married to actor Brad Pitt,
and lost her mother, Marcheline Bertrand, to ovarian cancer in 2007 (Bio, 2014; Jolie,
2013; Michel, 2014).
I argue that Jolie’s announcement of breast removal and reconstruction surgery
was hailed because of more acceptable notions of the breasts and breast cancer in the
American society. Her decision was framed as coming from an empowered and informed
woman who understood her medical choices. On the other hand, the way the preventative
treatment for ovarian cancer was presented as secondary (that is, if it will take place at
all), coming after breast cancer, points to the fact that society is still hesitant to admit the
severity of ovarian cancer. As will be seen in the discussion below, when at-risk women
become aware of the preventative treatments available to them to offset both breast and
ovarian cancer, they choose breast removal first and talk about having the ovaries
removed later. This is understandable given that the risks of having the ovaries removed
are greater than those for removal of the breasts (Gessen, 2013). I argue, however, that
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this trend points to limited visibility for ovarian cancer and the discomfort associated
with imagining the disease much less talking about it publicly. But this does not make the
disease any less fatal.
This article is important because it highlights how illness metaphors influence
narratives and perceptions about that illness, related medical decisions, and where/on
whom the burden of responsibility is placed. It is hoped that this article will provoke the
public to consider how metaphors used to discuss the ovaries and ovarian cancer may be
inhibiting public discussions of the disease. Furthermore, this article fulfils, in part, calls
for more public discourse about ovarian cancer as a way of creating awareness and
education about the disease.
My aim in this article is not to suggest that Angelina Jolie’s decision was right or
wrong; neither am I implying what she should have done. I am also not advocating for
oophorectomy as a preventative treatment for ovarian cancer. I am only using her case to
highlight how society still perceives ovarian cancer; how current discussion (or nondiscussion) of ovarian cancer does little to highlight the severity of the disease even
though it is the deadliest of all gynecologic cancers. I argue that such public perception of
the disease needs to change if more awareness and education about the disease is to be
created and if the disease is to be brought to the public radar.
In the first part of this article, I lay out the theoretical framework including
usefulness of metaphors in shaping social constructions of issues, and medical metaphors
of the ovaries and ovarian cancer. Part II of the article uses the critical lens to analyze
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Angelina Jolie’s decision to have double mastectomy and possibly oophorectomy in the
future, as a preventative measure for cancer.
Part I: Theoretical Framework
How Metaphors Shape Narratives
Metaphors as used in narratives of illness take the form of those used by the
medical establishment and society to discuss an illness and those used by patients in
making meaning of their experience with an illness. Metaphors in the first category can
be used to cast negative or positive light on a disease and people’s experience with it and
reinforce stereotypes, hence the argument by some scholars to be weary when using
metaphors (Sontag, 1997). On the other hand, metaphors used to express one’s
embodiment of an illness and describe exactly how one experiences the illness are
pertinent (Holmes, 2011). This is because metaphors enable access to and/or
understanding of the feelings and expressions of other people, and have the potential to
create relationships (Holmes, 2011). Thus, while there is a need to refrain from using
certain metaphors because they kill and present the ill and illness in a negative light
(Sontag, 1997), we cannot completely stop using metaphors as doing so will be like
“ceasing to eat or to breathe” (Holmes, 2011, p. 265).
Lakoff and Johnson (1980) notes that we live within and by metaphoric
constructions; metaphors influence relations to the self and others, our perceptions,
thought processes, and actions. Metaphors help create and define realities; they shape
realities by highlighting some aspects of an issue and hiding other aspects (Holmes, 2011;
Lakoff & Johnson, 1980). Metaphors shape the narratives we make of the experiences we
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go through in life; we make meaning of experiences in our bodies based on knowledge of
the self and the culture in which we live—based on a “process of triangulation between
inside and outside data points” (Holmes, 2006, p. 478). Thus, metaphors and the issues
and experiences they are used to describe are important because they influence individual
and policy actions taken towards those issues; these metaphors leave residues of varied
emotions depending on how they are used and the meaning conveyed (Holmes, 2011).
Hence, we need to determine which metaphors matter in terms of influencing the
thoughts and actions of people. This is because metaphors influence the “imaginary
narratives” (Holmes, 2011, p. 265) constructed around a particular issue; metaphors
determine narratives.
Metaphors have long been used in discussions around cancer. The military
metaphor including expressions such as “fight,” “overcoming” and “war on cancer” is the
most prevalent in cancer medicine (Jasen, 2009; Penson, Schapira, Daniels, Chabner &
Lynch, 2004). In the case of ovarian cancer, for instance, metaphors used to discuss and
describe the ovaries and ovarian cancer, to a greater extent, influence societal perception
and understanding of the disease. Thus, much as metaphors about the ovaries and ovarian
cancer sometimes negatively influence public perception of the disease, these metaphors
are nonetheless important for meaning-making; lack of the appropriate metaphors can
produce “imaginative gaps” and influence actions taken in relation to the disease such as
calling the doctor to complain about symptoms (Holmes, 2006).
Metaphors of the Ovaries and Ovarian Cancer
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Historically, the ovaries were believed to be responsible for a host of disorders in
women including excessive desire for sex, overeating, attempted suicide, and painful
menstruation, leading to a surge in medical procedures to remove the ovaries not as a way
of treating diseases of the ovary but to control other sociocultural problems believed to
have been caused by the ovaries (Barker-Benfield, 1972; Gubar, 2012; Holmes, 2006).
This “female castration” was invented in 1872 by Robert Battey who resolutely defended
the procedure even when evidence suggested that the procedure did not cure the supposed
abnormalities in women. It turned out the nature and functions of the ovaries were
misunderstood at the time. The ovaries were projected as responsible for almost all
disorders in women and society, an explanation that was accepted by some women who
began to look at the ovaries with suspicion; the ovaries were projected as monstrous, to
be precise. Needless to say that these perceptions of the ovaries were based in societal
beliefs about gender roles, with an aim to protect male identity (Barker-Benfield, 1972).
Metaphors used to discuss the ovaries are often not pleasant, producing unsavory
images in the mind of the public and inspiring women to do all they can to detach
themselves from these organs (Holmes, 2006). As explained by Holmes (2006), most of
the visual representations of ovarian cancer in the public sphere use the image of flowers.
Diseased ovaries are usually depicted in the form of dead and/or diseased flowers. The
imageries created by these visual representations are those of lack of energy, depletion
and demise (Holmes, 2006). Actual images of ovarian tumors are also not appealing, thus
discouraging the public from thinking and talking about ovarian cancer (Holmes, 2006;
Stacy, 1997). Ovarian tumors can be “monstrous and fascinating,” to use the words of
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Stacey (1997); they are usually very large and some can contain bodily parts such as
teeth, hair and nails (Stacey, 1997). This, coupled with a history of use of medical
metaphors to describe processes in the female body including menstruation and
menopause as a failure of some sort (Martin, 2001), does not help in constructing a
positive narrative about ovarian cancer. It is noteworthy that menstruation and menopause
come about as a result of functions of the ovaries; hence not surprising that the ovaries
are often despised since menstruation and menopause also used to be considered
abnormalities. The ovaries are often projected as sites for deficiencies and excess, a
description that shapes public perception of the organs and ovarian cancer (Holmes,
2006). For instance, Crossen (1942) argued for removal of the ovaries after menopause
because the ovaries have “fulfilled their reproductive and endocrine functions. They are
no longer an important part of the economy but vestigial structures which carry a special
tendency toward cancer” (p. 1487). She noted further that female sexual desires and
instincts may exist without the ovaries; basically that the functioning of the female body
can continue without the ovaries.
The breasts, on the other hand, are seen as essential elements of femininity and
sexuality; defining organs women cannot do without. This portrayal of the breasts has
influenced understanding of breast cancer not only as a physical disease but as a disease
that threatens womanhood, hence deserving public attention (Michel, 2014). Additionally,
the position of the breasts on the female body makes it visible enough to “invite” and
encourage public discourse, although the discourse is often feminine in nature (Holmes,
2006; Michel, 2014). Images of the breasts and breast cancer in public sphere are often
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positive and beautiful, a way of reclaiming the feminine beauty lost to the disease
(Holmes, 2006; Michel, 2014; Sulik, 2011). And of course breast cancer lends itself more
to the battle-like cancer metaphors because of the high survival rate, compared with
ovarian cancer which most of the time has poor prognosis thus fitting to use metaphors
that portray the disease as an enemy which attacks without warning (Gubar, 2012; Jasen,
2009).
Drawing from Martin’s (2001) argument that metaphors used to describe
menopause and menstruation imply a failure of the female system to produce, I argue that
metaphors and visual representations of the ovaries create negative views of ovarian
cancer and subtly encourage detachment from the ovaries. This leads to limited
discussions of the disease in the public sphere and subsequently limited awareness about
the disease. “Ovarian tumors . . . are not part of our daily vocabulary for either drama or
hypochondriac humor,” remarks Holmes (2006, p. 491). There are other narratives of the
disease presented in film and some television programs including Margaret Edson’s play
Wit (1999 as cited by Gubar, 2012; Deshazer, 2003) which can foster understanding of
the disease and invoke activism (Deshazer, 2003; Holmes, 2001); however, these are rare.
Holmes (2011) blames the timing of her diagnosis with ovarian cancer on the
limited public metaphors—“public imaginative gap” (Holmes, 2006, p. 477)— for the
ovaries and ovarian cancer; she had limited metaphors to articulate the symptoms she was
experiencing in her body. Indeed, there is limited public knowledge about ovarian cancer
(National Ovarian Cancer Coalition, n.d.). This situation is complicated by the
“unvisualizable” nature of the disease (Holmes, 2006, p. 488); there are no signs on the
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body to help visualize it. However, patients and survivors of the disease claim ovarian
cancer actually speaks through its symptoms but the “speech of ovarian cancer” (Gubar,
2012, p. 16) is often unheard or unheeded by both patients and physicians. The symptoms
are very general that they are often attributed to other conditions such as menopause,
yeast infection, and indigestion (Gubar, 2012)
This confirmation from patients and survivors that the disease actually presents
signs has led to a shift in metaphors used to describe the disease from the “silent killer” to
the “whispering disease” (Jasen, 2009). This shift is important given that the type of
metaphor used to describe and discuss the disease can be powerful in shaping
understanding of the disease, causing misinformation and diverting attention from
symptoms (Jasen, 2009). As argued by Homles (2006), using metaphors such as
“whispering,” “silent” and “killer” to describe the disease points to a public attitude of
shame toward to the ovaries and ovarian cancer since people whisper about things they
are ashamed to openly talk about. Thus, I contend that this perception of the disease is so
engrained in the public sphere that people feel more comfortable talking about other
women cancers such as breast cancer than ovarian cancer. It is distressing to discuss
ovarian cancer in private life, let alone in public, probably because the disease usually has
no “happily-ever-after” endings (Gubar, 2012, p. 23).
While campaigns by nonprofit organizations to raise awareness about ovarian
cancer can aid erase stereotypes about the disease, campaign artifacts including bracelets
and ribbons minimize the severity of the disease and make it harder for the public to
visualize the disease—to visualize what it is like to have ovarian cancer (Homes, 2006).
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The situation is made harder by the visual culture in which we live which makes it
difficult for people to visualize their interior organs (Holmes, 2006). The ovaries are
hidden in the body hence there is no visual mark on the body to invite people to visualize
it, compared to the breasts (Holmes, 2006). Ovarian cancer remains somewhat visible to
the medical eyes only; very few people think about the ovaries unless there is a medical
reason to do so and even then, that has to be done with the assistance of medical
personnel or technology (Holmes, 2006). Therefore, our view and understanding of the
ovaries and ovarian cancer is often mediated mainly because of the position of the organs
in the body; a situation that further promotes alienation from the ovaries and less talk
about ovarian cancer. Medical practitioners “appear to be more directly engaged with the
disease than the person whose body contains it,” Gubar (2012, p. 62) attests.
Part II: Evidence from Popular Culture
Many people in American society have been affected by ovarian cancer and many
women have died from it; among these are well-known figures in popular culture.
However, most of the time when ovarian cancer is discussed in the public sphere, hardly
are any of these people mentioned. This is probably because most of these personalities
did not survive the disease and as noted by Gubar (2012) stories with no happily-everafter endings are hard to receive by the public. For instance, Coretta Scott King, widow
of Martin Luther King, died of ovarian cancer in 2006 at the age of 78. She was
diagnosed at stage III of the disease (Applebome, 2006). Pop music singer and songwriter
Laura Nyro also died of ovarian cancer in 1997 at the age of 49. Nyro was diagnosed in
1995 and died two years later; her mother also died of ovarian cancer years earlier
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(Holden, 1997; Biography, 2015). Another public figure who died of ovarian cancer is
Elizabeth Tilberis, editor-in-chief of Harper's Bazaar magazine. Ms. Tilberis used her
situation to educate the public about ovarian cancer with two informative articles on the
disease appearing in the magazine in 1994 and 1996; she also wrote about her battle with
the disease in a book titled “No Time to Die”. Ms. Tilberis became president of the
Ovarian Cancer Research Fund in 1997 and died in 1999 at age 51 (Schiro, 1999). More
recently, too, America lost Diem Brown, the MTV reality star, to ovarian cancer. She died
in 2014 at age 34. For the purposes of this article, I will focus on Angelina Jolie’s case.
Jolie does not have ovarian cancer but has a risk of the disease.
Angelina Jolie’s Decision with her Breasts and Ovaries
On May 14, 2013 U.S. actress and director Angelina Jolie announced in an op-ed
in The New York Times that she had had double mastectomy as a preventative measure
because of an inherited mutated BRCA1 gene and a family history of cancer (Jolie,
2013). A decision which has come to be known as “Angelina Jolie effect” because of the
influence it has had on other women to get genetic testing and take preventative measures
(Kluger & Park, 2013; Sunnybrooks Health Sciences Center, 2014). Jolie notes her gene
mutation put her at 87% chance of getting breast cancer and 50% chance of having
ovarian cancer. She explains her decision to have her breasts removed first was because
her risk of breast cancer was higher than that for ovarian cancer and because of the
complexity of the breast removal procedure. There was no mention of when she would
take care of the ovaries. She describes her decision as “proactive” and as a way of
managing the risk of having cancer (Jolie, 2013).
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Jolie was shown as owning her decision, as evident in the title of the op-ed “My
Medical Choice” (Jolie, 2013). She also talked about her mother’s death to ovarian cancer
and how she did not want to put her children through similar pain by death to cancer. She
says,
“We often speak of “Mommy’s mommy,” and I find myself trying to explain the
illness that took her away from us. They have asked if the same could happen to
me. I have always told them not to worry . . .” (Jolie, 2013, para. 2).
Thus, her decision to undergo double mastectomy and future plans to remove her ovaries
was influenced by considerations of past and future pains and/or suffering related to
cancer. She witnessed her mother’s suffering and did not want to put herself and family
through a similar situation. Hallowell (2006) argues that such considerations play a big
part in cancer risk management decisions by at-risk women. Furthermore, Jolie indicated
having been educated about her risk and treatment options, and brought out her selfless
motive for coming public with her decision by saying it was for the benefit of other
women:
I wanted to write this to tell other women that the decision to have a mastectomy
was not easy . . . For any woman reading this, I hope it helps you to know you
have options. I want to encourage every woman, especially if you have a family
history of breast or ovarian cancer, to seek out the information and medical
experts who can help you through this aspect of your life, and to make your own
informed choices (Jolie, 2013, para. 11, 14).
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Presentation of such a radical medical decision as the choice of an empowered,
well-informed woman influenced how the public received the news. After her decision
was made public, Jolie was hailed by sections of the U.S. public as brave, courageous and
as setting an example for other women (Kluger & Park, 2013; Michel, 2014). Indeed, so
widespread was the effect of her decision on other women that there was reportedly an
increase in genetic testing and counselling among at-risk women after her announcement
(Michel, 2014; Sunnybrooks Health Sciences Center, 2014).
Giving more visibility to the Breasts than the Ovaries, Again
Bold and empowering as Jolie’s decision may seem, implicit in such a move is a
seeming neglect of an equally devastating women’s cancer, ovarian cancer. The op-ed
was about her mastectomy, with little hint of future plans to remove her ovaries also. The
difference between Jolie’s risk of getting breast cancer and her risk of ovarian cancer was
27%, hence her decision to take care of the breasts first. This is understandable
considering her age (37 years old) and the fact that removing her ovaries can lead to early
menopause and other medical problems. The procedure reduced her chances of getting
breast cancer to under 5% (Jolie, 2013). She had this to say of her breast reconstruction
surgery:
It is reassuring that they [her children] see nothing that makes them
uncomfortable. They can see my small scars and that’s it. Everything else is just
Mommy, the same as she always was (Jolie, 2013, para. 12).
However, I ask: how about her risk of ovarian cancer? What about the fact that
Jolie is at higher risk of dying from ovarian cancer than from breast cancer? Jolie lost her
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mother to ovarian cancer in 2007. Certainly ovarian cancer is not as high on the public
radar as breast cancer is. Could this be as a result of societal perceptions of the ovaries
and ovarian cancer based on metaphors often used to describe the disease? Why were the
ovaries ignored, even if temporarily? Is it because they are positioned in the interior of
the body as such do not draw attention to themselves as do the breasts? These were the
questions flooding my mind as I read the op-ed in the New York Times.
I argue that Jolie’s decision points to the lack of public discourse about ovarian
cancer in American society; ovarian cancer discourse is muted by discourse around more
“popular” cancers such as breast cancer. Indeed, the American media space was filled
with discussions about breast cancer following Jolie’s announcement; but very little was
said about ovarian cancer during that time, as always. This goes to support claims that
ovarian cancer does not lend itself well to the “early diagnosis,” “overcoming” and “war”
rhetoric of breast cancer, thus limiting public discourse about the disease (Jasen, 2009).
The ovaries are not glamorous in reality and depictions of them in the public sphere are
also abysmal thus discouraging the public from thinking and talking about ovarian cancer
(Holmes, 2006). But if we do not talk about the disease, how will the public, and women
in particular, learn to pay attention to the organs and catch signs of ovarian disease early?
If in expressing our “medical choices” we give prominence to the “big name” cancers to
the neglect of the less popular ones such as ovarian cancer, how is the public to be
sensitized that ovarian cancer exists, is affecting many lives, and is deadly? These are
question society including scholars with interests in feminist and women’s issues,
communication scholars, and other stakeholders need to be deliberating even as we aim
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to increase awareness and education about ovarian cancer, and deconstruct gendered
notions of the disease.
As argued elsewhere in the media, some commentators suggest it was not
necessary for Jolie to consider removing her ovaries even though doing so would reduce
her risk of ovarian cancer down to a single digit as well. These people argue that having
her ovaries removed was too risky and may be uncalled-for (Gessen, 2013; Ji, 2014).
They note further that ovarian cancer is over-diagnosed such that women who in fact do
not have the disease end up going through treatments for the disease, leading to
unnecessary pain and inflated statistics about the disease (Ji, 2014). This proposition is
meaningful; but I argue that such discussions about the disease and its treatment options
only increase public misconceptions about the disease and further silence discussions
about the disease.
Indeed, the breasts and ovaries symbolize different things in society: one as a
symbol of sexuality and femininity and the other as a symbol of production and/or nonproduction (Holmes, 2006; Langellier & Sullivan, 1998; Martin, 2001; Michel, 2014).
The ovaries and breasts are sites of conflicting cultural and social meanings of what it
means to be woman. The body in ovarian cancer is also the battleground for “fighting” a
disease science and medicine are trying so hard to gain a handle on, a situation which
leads to subjection of the female body to grueling and sometimes dehumanizing
treatments (Gubar, 2012). While more work has been done over the years to deconstruct
the effects of breast cancer on a woman’s body image and sexuality and hence increased
positive public perception of breast cancer (Langellier & Sullivan, 1998), little work has
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been done on ovarian cancer. This has made talks about the breasts and breast cancer
common while there is still struggle to openly discuss the ovaries and ovarian cancer.
There are limited survival accounts/narratives of ovarian cancer, compared to breast
cancer, because the disease is still less known and because the treatment regimen is
grueling that survivors’ accounts may not be inspiring if they want to be honest about
their experiences; and of course “it is hard to read stories with no happily-ever-after
endings” (Gubar, 2012, p. 23).
Conclusion
Drawing from the literature on how metaphors of the ovaries and ovarian cancer
can influence public perception of and discourse about ovarian cancer, I used Angelina
Jolie’s decision to have her breasts removed (and perhaps her ovaries at a later date) as a
cancer preventative measure to argue that metaphors still influence perceptions of illness.
I argue that how Jolie’s medical decision was constructed as coming from an empowered,
well-informed woman, her owning of the decision and projecting her coming public with
it as a way to empower other women, in addition to sexualized perceptions of the breasts,
influenced how the public received her news. However, her narrative did not touch on
ovarian cancer even though her risk of dying from ovarian cancer was greater. This points
to the limited presence ovarian cancer has in the American public sphere, a situation I
argue may be due to the metaphors used to discuss the ovaries and ovarian cancer.
As noted, the aim of this article was not to imply that Angelina Jolie’s decision
was right or wrong; neither am I advocating for oophorectomy. I only used her case to
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show how current discussion (or non-discussion) of ovarian cancer does little to highlight
the severity of the disease.
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